New Therapies with Novel Mechanisms of Action Are Urgently Needed for Type 2 Diabetes
The Time Is Now to Promote Aggressive Lipid Management to Prevent Macrovascular Complications in Patients with Type 2 Diabetes
Anticoagulation Bridging Therapy after Total Hip or Knee Replacement: A Missed Opportunity?
Potential Cost-Savings Using a Treatment Algorithm for Problem Bleeding Episodes in Patients with Hemophilia and Inhibitors
A Collaborative Approach to Drug Selection, Driven by Clinical Outcomes Excellence
Health Plans Must “COPE” with Chronic Diseases
Stakeholder Integration Crucial to Improved Patient Outcomes: Lessons from a Health Plan’s Experience
Page 12 of 15
Results 111 - 120 of 144
Copyright © The Lynx Group, LLC. All rights reserved.